TORRENT PHARMACEUTICALS

BSE: 500420 30 Sep 2025

Healthcare

₹ 3596.2

Torrent Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

TORRENT PHARMACEUTICALS

BSE: 500420 30 Sep 2025

Healthcare

₹ 3596.2

Torrent Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

224.0

Dividend Yield

0.9%

Debt to Equity

0.42

Stock P/E

59.7

Market Cap

1,20,515 Cr

TORRENT PHARMACEUTICALS - Share Price & Details

Market Cap

₹1,20,515

High /Low

3,790 / 2,886

Stock P/E

59.7

Book Value

₹224.0

Dividend Yield

0.9

ROCE

27.0

ROE

₹26.5

Face Value

5.0

PEG Ratio

2.82

EVEBITDA

₹32.3

Debt

3,202

CMP / FCF

52.3

Debt to equity

₹0.42

NP Ann

1,911

High price all time

3,790

Piotroski score

₹9.0

Graham Number

546.0

No. Eq. Shares

33.8

Net CF

₹-262

Net profit

2,002

Price to book value

15.9

Interest Coverage

₹12.9

Low price all time

26.3

Industry PE

33.0

Reserves

₹7,421

Free Cash Flow

₹1,991

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
29 Aug 2025	Mirae Asset Sharekhan	Buy	₹3,558.85	₹4,024	12.2%	moneycontrol	View
29 Jul 2025	Prabhudas Lilladher	Buy	₹3,768.35	₹4,000	6.1%	moneycontrol	View
29 Jul 2025	ICICI Securities	Hold	₹3,768.35	₹3,530	-5.3%	moneycontrol	View
01 Jul 2025	Prabhudas Lilladher	Buy	₹3,409.7	₹3,850	12.6%	moneycontrol	View
01 Jul 2025	ICICI Securities	Hold	₹3,409.7	₹3,500	2.4%	moneycontrol	View
30 Jun 2025	Motilal Oswal	Hold	₹3,409.7	₹3,430	0.6%	moneycontrol	View
21 May 2025	Prabhudas Lilladher	Buy	₹3,243.35	₹3,670	11.5%	moneycontrol	View
27 Jan 2025	Prabhudas Lilladher	Buy	₹3,247.75	₹3,750	12.3%	moneycontrol	View
25 Jan 2025	Motilal Oswal	Hold	₹3,247.75	₹3,410	2.8%	moneycontrol	View
27 Oct 2024	Prabhudas Lilladher	Buy	₹3,437.65	₹3,600	6.6%	moneycontrol	View
25 Oct 2024	Sharekhan	Buy	₹3,437.65	₹4,232	25.4%	moneycontrol	View
01 Aug 2024	Geojit Financial Services	Buy	₹3,215.4	₹3,590	6.7%	moneycontrol	View
24 Jul 2024	Prabhudas Lilladher	Buy	₹3,148.4	₹3,300	-1.8%	moneycontrol	View
23 Jul 2024	Motilal Oswal	Hold	₹3,137.15	₹3,340	-0.6%	moneycontrol	View
27 May 2024	Prabhudas Lilladher	Buy	₹2,654.05	₹2,900	-13.7%	moneycontrol	View
24 May 2024	Sharekhan	Buy	₹2,612.05	₹2,954	-12.1%	moneycontrol	View
05 Jan 2024	Sharekhan	Buy	₹2,343.65	₹2,700	-19.7%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
TORRENT PHARMACEUTICALS LTD.	26110.0	5510.0	26160.0	16.28	1,20,515	59.7
Max Healthcare Institute Limit	7738.7	1660.3	6940.2	1.7	109221	91.0
APOLLO HOSPITALS ENTERPRISE LT	22004.0	3069.0	21679.0	21.35	107982	68.6

Peer Comparison Chart

About TORRENT PHARMACEUTICALS

Torrent Pharmaceuticals Ltd., with Security Code 500420, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Acquisition News: Torrent Pharma gets CCI approval to buy controlling stake in THIS chemical company

(24 Sep 2025)

Torrent Pharma Acquisition Of JB Chemicals and Pharmaceuticals: Torrent Pharmaceuticals is the flagship company of the Torrent group and is...

Top stocks in news: VMS TMT, Swiggy, HCL Tech, Torrent Pharma, Akzo Nobel, Torrent Power

(24 Sep 2025)

Stocks including VMS TMT, Swiggy, HCL Tech, Torrent Pharma, Akzo Nobel, Torrent Power, Ceinsys Tech, Lemon Tree, and more will be in the...

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	1,920.0	2,121.0	2,146.0	2,123.0	2,143.0	2,438.0	2,434.0	2,377.0	2,433.0	2,616.0
Expenses	1,342.0	1,384.0	1,410.0	1,422.0	1,427.0	1,539.0	1,513.0	1,490.0	1,565.0	1,637.0
Operating Profit	578.0	737.0	736.0	701.0	716.0	899.0	921.0	887.0	868.0	979.0
OPM %	30.1%	34.75%	34.3%	33.02%	33.41%	36.87%	37.84%	37.32%	35.68%	37.42%
Other Income	26.0	11.0	15.0	-11.0	76.0	21.0	-7.0	3.0	-9.0	-5.0
Interest	94.0	90.0	77.0	69.0	67.0	64.0	54.0	48.0	47.0	45.0
Depreciation	182.0	183.0	192.0	191.0	195.0	189.0	190.0	191.0	190.0	187.0
Profit before tax	328.0	475.0	482.0	430.0	530.0	667.0	670.0	651.0	646.0	742.0
Tax %	-33.2%	-32%	-32.2%	-30.9%	-22.6%	29.7%	-31.3%	-25.5%	-23.8%	25.7%
Net Profit	219.0	323.0	327.0	297.0	410.0	469.0	460.0	485.0	474.0	551.0
EPS in Rs	6.46	9.55	9.65	8.78	12.12	13.86	13.6	14.33	0	16.28

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	2,491.0	2,491.0	2,591.0	2,660.0	2,732.0	2,745.0	2,859.0	2,889.0	2,809.0	2,959.0
Expenses	1,767.0	1,764.0	1,800.0	1,835.0	1,863.0	1,862.0	1,955.0	1,950.0	1,895.0	1,995.0
Operating Profit	724.0	727.0	791.0	825.0	869.0	883.0	904.0	939.0	914.0	964.0
OPM %	29.06%	29.19%	30.53%	31.02%	31.81%	32.17%	31.62%	32.5%	32.54%	32.58%
Other Income	-10.0	9.0	34.0	26.0	55.0	31.0	24.0	-16.0	33.0	-42.0
Interest	102.0	107.0	103.0	91.0	80.0	80.0	75.0	64.0	57.0	56.0
Depreciation	193.0	196.0	191.0	201.0	213.0	203.0	197.0	198.0	199.0	201.0
Profit before tax	419.0	433.0	531.0	559.0	543.0	631.0	656.0	661.0	691.0	689.0
Tax %	-32.5%	-33.7%	-28.8%	-30.9%	-29.8%	-28.8%	-30.3%	31.5%	27.2%	-25.1%
Net Profit	283.0	287.0	378.0	386.0	443.0	449.0	457.0	453.0	503.0	498.0
EPS in Rs	8.36	8.48	11.18	11.39	13.1	13.27	13.51	13.37	14.88	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	11%
5 Years:	9%
3 Years:	13%
TTM:	13%

Compounded Profit Growth
10 Years:	12%
5 Years:	16%
3 Years:	25%
TTM:	42%

Stock Price CAGR
10 Years:	18%
5 Years:	20%
3 Years:	35%
1 Year:	19%

Compounded Sales Growth
10 Years:	10%
5 Years:	8%
3 Years:	11%
TTM:	7%

Compounded Profit Growth
10 Years:	10%
5 Years:	14%
3 Years:	21%
TTM:	22%

Stock Price CAGR
10 Years:	18%
5 Years:	20%
3 Years:	35%
1 Year:	19%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About TORRENT PHARMACEUTICALS

Order Book

Latest News

Acquisition News: Torrent Pharma gets CCI approval to buy controlling stake in THIS chemical company

Top stocks in news: VMS TMT, Swiggy, HCL Tech, Torrent Pharma, Akzo Nobel, Torrent Power

Torrent Pharmaceuticals allots commercial paper of Rs 200 cr

Torrent Pharmaceuticals Ltd soars 0.72%, gains for fifth straight session

Torrent Pharmaceuticals Ltd stays supported

Torrent Pharma to Merge with JB Chemicals in ₹19,500 Cr Deal

Sun Pharma, Cipla, Dr Reddy’s, Zydus Lifesciences, Divi’s Labs, Torrent Pharma et al: Parsing through the pharma value chain

Torrent Pharma Brand Misused in Online Investment Scam, Fake Portals Promising High Returns Busted

Who Is Aman Mehta—Heeramandi Actress Sharmin Segal’s Husband With A Rs 50,939 Crore Torrent Pharma Empire, $4.

Briefs: Torrent Pharmaceuticals and Hemant Surgical Industries

Torrent Pharma shares fall 1.42% on Wednesday; among top losers on Nifty Next 50

Stocks to Watch Today, Sep 11: Infosys, TVS Motor, Muthoot Finance, Torrent Pharma and others

Torrent Pharma to pick up 26% stake in subsidiary for new project

Torrent Pharma to Acquire 26 Percent Stake in Captive Hybrid Power Project in Gujarat

Those who invested in Torrent Pharmaceuticals (NSE:TORNTPHARM) five years ago are up 169%

Stocks to Watch: Torrent Pharma, RVNL, Eicher Motors and more

Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project

Torrent Pharma to acquire 26% stake in arm for Gujarat hybrid power project

Torrent Pharma to Acquire 26% Stake in Torrent Urja 27 for ₹7.92 Crore

Torrent Pharmaceuticals-J.B. Chemicals & Pharma merger requires South African antitrust nod

₹6,843 Cr Acquisition: Pharma stock in focus after Torrent Pharma to acquire 26% stake in the Co.

Torrent Pharma Announces Open Offer To Acquire Rs 6,843-Crore Stake In JB Chemicals

Buy Torrent Pharmaceuticals; target of Rs 4,024: Sharekhan

Pharma stocks take a hit as Trump issues fresh warning; key details

Torrent Pharma-JB Chemicals acquisition: Board approves Rs 19,500-cr deal – Know what shareholders will get

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?

Torrent Pharma not planning to make leadership changes after buying JB Pharma

Torrent Pharma Q1 net profit up 20% at Rs 548 crore

Torrent Pharma's Vizag facility cleared by USFDA with zero observations

Corner Office Conversation with The New Leaders of Indian Pharma

Torrent Pharma's Vizag facility clears USFDA inspection with zero observations

Torrent Pharmaceuticals Limited (500420)’s Trend in 2025 - Exceptional market performance

Torrent Pharma Hits 52-Week High on Q1 Profit Surge

Torrent Pharma: USFDA concludes inspection at Vizag facility with zero observations

Torrent aims to be among first cos to launch Wegovy, Ozempic generics in Brazil | Company Business News

Health and Wellness News: Torrent Pharma Extends Shelcal® brand into adult nutrition supplements

Torrent Pharmaceuticals Achieves All-Time High Stock Price Amidst Market Volatility

Hold Torrent Pharma: target of Rs 3530: ICICI Securities

Breakout Stocks: How to trade Torrent Pharma, EID Parry & Syrma SGS Technology that hit fresh 52-week high?

Street bullish on Torrent Pharma's prospects after in-line Q1 FY26

Accumulate Torrent Pharmaceuticals; target of Rs 4000: Prabhudas Lilladher

Trade Spotlight: How should you trade TCS, Cipla, Torrent Pharma, NCC, Paytm, SBI Life Insurance, UPL,...

Torrent Pharma gains over 2% after Q1 results; what should you do?

Stock Picks Today: IndusInd Bank, Torrent Pharma, GAIL Among Others On Brokerages Radar

Analysts bullish on this largecap pharma stock after Q1 earnings; expect up to 20% upside

BUY, SELL or HOLD stocks today: SAIL, IndusInd Bank, Torrent Pharma, Lodha Developers, Motherson and more

Torrent Pharmaceuticals Ltd gains for third straight session

Torrent Pharma Q1 net profit rises 20% on broad-based growth

Torrent Pharmaceuticals plans Semaglutide rollout post patent expiry

Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y

Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report

Torrent Pharma shares hit 52-week high post Q1 results

Stocks To Watch Today: IndusInd Bank, GAIL, Mazagon Dock, Torrent Pharma, Waaree Energies

Breakout Stocks: How to trade Laurus Labs, Torrent Pharma and Fortis Healthcare that hit a fresh 52-week high?

Indian drugmaker Torrent Pharma's quarterly profit jumps on strong demand

Torrent Pharma Q1 Review: Citi Hikes Target Price — Heres Why

Stock Radar: This pharma stock breaks out from a 9-month long consolidation phase; likely to fresh record

Top stock picks for July 28: Shyam Metalics, Torrent Pharma; check targets

Torrent Pharmaceuticals shares hit all-time high of Rs 3,630.70 on NSE

Pharma Stocks in Focus: Torrent Pharma Breaks Out, Accumulate on Dips Says Ajit Mishra

Breakout Stocks: How to trade Torrent Pharma, SBI Life and eClexr that hit fresh 52-week high?

गिरते बाजार में भी Torrent Pharma के शेयर 52 हफ्तों के हाई पर पहुंचे

Q1 results today: BEL, GAIL, IndusInd Bank, Adani Total, Torrent Pharma, Nippon Life to release earnings on July 28

Torrent Pharma Q1 Results: Net profit jumps 20% to Rs 548 crore

Torrent Pharma revenue up by 11% to Rs 3,178 crore in Q1 FY26

Torrent Pharma’s net profits grow 20% to ₹548 cr during Q1, FY26

Torrent Pharma Q1 Result | Net profit rises 20% to ₹548 crore; revenue, margin improves

Torrent Pharma Share Price Hits Life High After Citi Hikes Price Target Post Q1 Results

Torrent Pharma expands Shelcal brand into adult nutrition supplement powder